Cancer

News

Black Diamond becomes first biotech to announce IPO in 2020

Black Diamond Therapeutics has become the first biotech to announce an IPO in 2020, asking investors to fund a clinical trial to test its new approach to tackling cancer.

Views & Analysis

Sanofi Genzyme UK medical boss Marc Moodley discusses oncolo...

Marc Moodley has worked at Sanofi since 2018 and is the new medical head, UK and Ireland for the company’s Genzyme unit.

News

Boehringer cleared to manufacture BeiGene's cancer drug for ...

Boehringer Ingelheim is to manufacture the first biologic drug approved in China using a new regulatory system, designed to strengthen the country’s domestic pharma infrastructure.

News

Janssen J&J Johnson and Johnson pharmaceutical companies

J&J to buy US biotech Taris and its bladder cancer drug devi...

Johnson & Johnson is to buy the privately-owned biotech Taris, and a device that can deliver cancer drugs to the bladder.

News

FDA hastily approves Daiichi Sankyo/AZ's cancer drug, weeks ...

The FDA has approved an advanced breast cancer drug from AstraZeneca and Daiichi Sankyo in super-quick time.

News

AZ sells ex-US rights to old cancer drugs Arimidex and Casod...

For several years AstraZeneca has been selling off rights to its older drugs to raise cash as it develops a new generation of drugs, and this pattern has continued as it sold its Arimidex a

Black Diamond becomes first biotech to announce IPO in 2020

Sanofi Genzyme UK medical boss Marc Moodley discusses oncolo...

Boehringer cleared to manufacture BeiGene's cancer drug for ...

J&J to buy US biotech Taris and its bladder cancer drug devi...

FDA hastily approves Daiichi Sankyo/AZ's cancer drug, weeks ...

AZ sells ex-US rights to old cancer drugs Arimidex and Casod...

Getting predictive technologies to patients, with Concr

Discover a new era of healthcare panel engagement: Grounded ...

Cancer

Editor's Picks